Bioniche Life Sciences Inc. 25 Years
Contact Us Careers
Home Research
In the News

May 13, 2013
Bioniche Engages Evercore Partners to Assist in the Divestment of its Animal Health Business

May 8, 2013
Bioniche Life Sciences Inc. Reports Q3, Fiscal 2013 Results

Investors

Latest TSX stock price

All prices delayed at least 15 minutes.
Source: TSX Inc.

Latest ASX stock price

All prices delayed at least 20 minutes.
Source: ASX Inc.


Scientific Overview

 

  • *Alvaro Morales, MD, Christine Lihou, Zhihui Lang, MD, PhD, and Zvi Cohen, PhD. Use of Mycobacterial Cell Wall–DNA Complex Immediately After Endovesical Surgery in the Treatment of Patients With Non–Muscle-Invasive Bladder Cancer. 3rd European Multidisciplinary Meeting on Urological Cancers, Barcelona,, Spain, November 4-6, 2011. View Poster
  • Louisa Zak, Jennifer Patterson, Duncan Hockley, Mike Dyck, George Foxcroft and Dragan Rogan. Experience with single fixed-time AI protocols. Swine Breeding Management Workshop, Edmonton, Alberta, April, 2011.
  • Alvaro Morales, Harry Herr, Gary Steinberg, Ashish Kamat, Robert Given, Christine Lihou, Zvi Cohen. Efficacy and Safety of Mycobacterial Cell Wall DNA Complex in the Treatment of Patients with Non-Muscle Invasive Bladder Cancer at High Risk of Progression and Refractory to BCG. European Association of Urology (EAU) World Congress, Vienna, Austria, March, 2011. View Poster
  • Louisa Zak, Jennifer Patterson, Audrey Cameron, Duncan Hockley, Mike Dyck, George Foxcroft and Dragan Rogan. Benefits of fixed-time single or double breeding protocols in the weaned sow. American Association of Swine Veterinarians 2011 Annual Meeting, Phoenix, Arizona, March, 2011.

Copyright 2004, Bioniche Life Sciences Inc. All rights reserved  |  Legal Disclaimer  |  Privacy Policy